increased anxiety on semaglutide The risk of depression, anxiety, and suicidal behavior in patients with obesity glucagon like peptide-1 receptor agonist therapy MHRA finds no link between

protocols YG21113 and ZO23242) and performed in compliance with applicable animal welfare regulations

The Medicines and Healthcare products Regulatory Agency (MHRA) and manufacturers' Summaries of Product Characteristics (SmPCs) consistently advise against using GLP-1 receptor agonists whilst breastfeeding due to insufficient data on excretion into human breast milk and potential effects on nursing infants

James Carter, MD | Last Updated: July 2026 Semaglutide dosing in units matters because most Semaglutide vials are measured in milligrams, while the syringes patients use are marked in units, and mixing the two up can lead to an incorrect dose

Within weeks, the swelling in my neck eased, the puffiness faded, andbelieve it or noteven that itching that used to drive me crazy was finally gone (I laughed with my husband and said, Well, at least now I can sit through a whole TV show without squirming like Im on a hot seat!).

If weight loss plateaus after 4 to 6 weeks, the next step is either a dose increase, a drug holiday, or transitioning to a combination product like Qsymia